Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G H Talbot

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2001
Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristinP K Linden, R C Moellering, C A Wood, et al.
Journal of Clinical Microbiology|July 1, 1988
Multiply high-level-aminoglycoside-resistant enterococci isolated from patients in a university hospitalI Nachamkin, P Axelrod, G H Talbot, et al.
Clinical Therapeutics|April 22, 1999
Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis. Sparfloxacin Multicenter AMS Study GroupD C Henry, D J Moller, J Adelglass, et al.
Clinical Therapeutics|June 11, 1999
Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infectionsB A Lipsky, B Miller, R Schwartz, et al.
Surgery, Gynecology & Obstetrics|August 1, 1990
A survey of exposures, practices and recommendations of surgeons in the care of patients with human immunodeficiency virusD A Mandelbrot, W R Smythe, S A Norman, et al.
Clinical Therapeutics|January 7, 1998
Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: a randomized, double-masked, comparative, multicenter studyG R Donowitz, M L Brandon, J P Salisbury, et al.
Annals of Internal Medicine|December 1, 1987
What is the cost of nephrotoxicity associated with aminoglycosides?J M Eisenberg, H Koffer, H A Glick, et al.
Clinical Therapeutics|August 10, 1999
Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study GroupD C Henry, R C Nenad, A Iravani, et al.
Zentralblatt Fur Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology|July 1, 1986
Detection of fungal antigen in body fluids for diagnosis of invasive aspergillosisM H Weiner, G H Talbot, S L Gerson, et al.
Antimicrobial Agents and Chemotherapy|May 21, 1998
Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristinG M Eliopoulos, C B Wennersten, H S Gold, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2001
Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristinP K Linden, R C Moellering, C A Wood, et al.
Journal of Clinical Microbiology|July 1, 1988
Multiply high-level-aminoglycoside-resistant enterococci isolated from patients in a university hospitalI Nachamkin, P Axelrod, G H Talbot, et al.
Clinical Therapeutics|April 22, 1999
Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis. Sparfloxacin Multicenter AMS Study GroupD C Henry, D J Moller, J Adelglass, et al.
Clinical Therapeutics|June 11, 1999
Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infectionsB A Lipsky, B Miller, R Schwartz, et al.
Surgery, Gynecology & Obstetrics|August 1, 1990
A survey of exposures, practices and recommendations of surgeons in the care of patients with human immunodeficiency virusD A Mandelbrot, W R Smythe, S A Norman, et al.
Clinical Therapeutics|January 7, 1998
Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: a randomized, double-masked, comparative, multicenter studyG R Donowitz, M L Brandon, J P Salisbury, et al.
Annals of Internal Medicine|December 1, 1987
What is the cost of nephrotoxicity associated with aminoglycosides?J M Eisenberg, H Koffer, H A Glick, et al.
Clinical Therapeutics|August 10, 1999
Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study GroupD C Henry, R C Nenad, A Iravani, et al.
Zentralblatt Fur Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology|July 1, 1986
Detection of fungal antigen in body fluids for diagnosis of invasive aspergillosisM H Weiner, G H Talbot, S L Gerson, et al.
Antimicrobial Agents and Chemotherapy|May 21, 1998
Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristinG M Eliopoulos, C B Wennersten, H S Gold, et al.
Pageof 8